Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT02414451
Eligibility Criteria:
Inclusion Criteria:
* For participants with autism: High-functioning, native-English speaking subjects with ASD aged 15-30. High-functioning ASD is defined in this study by the DSM-V criteria plus Autism Diagnostic Interview-Revised (ADI-R) criteria for Autism, and Wechsler Abbreviated Scales of Intelligence (WASI) full scale IQ of at least 85.
Exclusion Criteria:
* For participants with autism: Non-autism learning disability (e.g. dyslexia),
* major psychiatric diagnosis (e.g. major depression, schizophrenia, bipolar disorder),
* other neurological diagnosis,
* major head trauma,
* any of the following exclusionary criteria related to propranolol (diabetes, reactive airway/pulmonary disease, thyroid disease, bradyarrhythmias, unexplained syncope, narrow angle glaucoma, pregnancy, known hypersensitivity/adverse reaction to beta-blockers),
* any of the following exclusionary criteria related to placebo (severe allergy to lactose),
* any of the following exclusionary criteria related to the psychophysiological measurements (history of rash from adhesives).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
30 Years
Study:
NCT02414451
Study Brief:
Protocol Section:
NCT02414451